The prolonged use or abuse of decongestants in general may lead to rebound congestion or drug induced rhinitis.
Indication
Allergic rhinitis accompanied by nasal congestion
Contra Indication
Contraindicated in patients with a known hypersensitivity to any ingredients of the preparation.
Dose
N/A
Side Effect
No serious side effects have been reported. Occasional irritation of the nasal mucosa may occur during the first day of use. In rare cases with Sodium Cromoglicate solutions alone wheezing and tightness of the chest has been reported. Because a lower dose of Xylometazoline is employed in this preparation it causes mild side effects such as nasal irritation, dryness of the nose, sneezing, headache, insomnia, drowsiness and palpitations.
Pregnancy Category
Name :
Not Classified
Description
FDA has not yet classified the drug into a specified pregnancy category.
Mode of Action
Sodium Cromoglycate inhibits degranulation of mast cells and therefore suppresses the release of histamine, leukotrienes and slow-reacting substance of anaphylaxis.
Xylometazoline is a direct-acting sympathomimetic which has a vasoconstrictor effect by reducing swelling and congestion when applied to mucous membranes.
Interaction
Xylometazoline hydrochloride....Increased heart rate or BP with sibutramine.
Potentially Fatal: Hypertensive crisis with MAOIs.
Pregnancy Category Note
N/A
Adult Dose
Adults (including the elderly): One spray each nostril four times daily.
Child Dose
Children: One spray each nostril four times daily.
Renal Dose
N/A
Administration
N/A
Disclaimer
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.